Article Details

Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism

Retrieved on: 2024-10-08 23:08:12

Tags for this article:

Click the tags to see associated articles and topics

Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism. View article details on hiswai:

Excerpt

20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that the U.S. Food ...

Article found on: quantisnow.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo